The Effect of Two Methods of HepatitisB Vaccination in Hemodialysis Patients (20-Months Follow-Up)

Background: Hemodialysis patients are at risk for infection with hepatitis B virus; so, hepatitis B vaccination is critical in these patients. Different methods are used to improve immunity of hemodialysis patients with different and controversial results. The aim of this study was to compare the ef...

Full description

Bibliographic Details
Main Authors: Ali Momeni, Soleiman Kheiri, Zahra Khadivi
Format: Article
Language:fas
Published: Isfahan University of Medical Sciences 2012-08-01
Series:مجله دانشکده پزشکی اصفهان
Online Access:http://jims.mui.ac.ir/index.php/jims/article/view/1927
_version_ 1797708375210852352
author Ali Momeni
Soleiman Kheiri
Zahra Khadivi
author_facet Ali Momeni
Soleiman Kheiri
Zahra Khadivi
author_sort Ali Momeni
collection DOAJ
description Background: Hemodialysis patients are at risk for infection with hepatitis B virus; so, hepatitis B vaccination is critical in these patients. Different methods are used to improve immunity of hemodialysis patients with different and controversial results. The aim of this study was to compare the effect of hepatitis B vaccination by itradermal low dose versus intramuscular high dose vaccines in hemodialysis patients’ short- and long-time follow-up. Methods: In a cross-sectional study, 24 hemodialysis patients not responded to conventional method of vaccination, were enrolled to intramuscular or intradermal groups randomly. The antibody titer was checked after 1 and 3 months of the end of vaccination. In 16 remaining patients, antibody titer was rechecked also after 14 and 20 months. Findings: In studied patients, the mean HBS antibody titer was 4.4 ± 3.1 mu/ml at the beginning of study; and 190.4 ± 59 and 223.3 ± 83.9 mu/ml after 1 and 3 months follow-up, respectively (P < 0.001). In remaining patients, the mean antibody titer after 14 and 20 months follow-up was 144 ± 164.2 and 45.2 ± 34 mu/ml, respectively (P < 0.001). Conclusion: Response to vaccination at short time in two groups was very good but after 14 months, the antibody titer decreased and the decline of antibody titer continued until 20 months. Keywords: Hepatitis B, Vaccination, Hemodialy
first_indexed 2024-03-12T06:21:31Z
format Article
id doaj.art-298ceeb8e0474a5380f1ca52328fe9c8
institution Directory Open Access Journal
issn 1027-7595
1735-854X
language fas
last_indexed 2024-03-12T06:21:31Z
publishDate 2012-08-01
publisher Isfahan University of Medical Sciences
record_format Article
series مجله دانشکده پزشکی اصفهان
spelling doaj.art-298ceeb8e0474a5380f1ca52328fe9c82023-09-03T02:11:05ZfasIsfahan University of Medical Sciencesمجله دانشکده پزشکی اصفهان1027-75951735-854X2012-08-01301921083The Effect of Two Methods of HepatitisB Vaccination in Hemodialysis Patients (20-Months Follow-Up)Ali Momeni0Soleiman Kheiri1Zahra Khadivi2Associate Professor, Department of Internal Medicine, School of Medicine, Shahrekord University of Medical Sciences, Shahrekord, IranAssociate Professor, Department of Biostatistics and Epidemiology, School of Public Health, Shahrekord University of Medical Sciences, Shahrekord, IranGeneral Practitioner, Shahrekord University of Medical Sciences, Shahrekord, IranBackground: Hemodialysis patients are at risk for infection with hepatitis B virus; so, hepatitis B vaccination is critical in these patients. Different methods are used to improve immunity of hemodialysis patients with different and controversial results. The aim of this study was to compare the effect of hepatitis B vaccination by itradermal low dose versus intramuscular high dose vaccines in hemodialysis patients’ short- and long-time follow-up. Methods: In a cross-sectional study, 24 hemodialysis patients not responded to conventional method of vaccination, were enrolled to intramuscular or intradermal groups randomly. The antibody titer was checked after 1 and 3 months of the end of vaccination. In 16 remaining patients, antibody titer was rechecked also after 14 and 20 months. Findings: In studied patients, the mean HBS antibody titer was 4.4 ± 3.1 mu/ml at the beginning of study; and 190.4 ± 59 and 223.3 ± 83.9 mu/ml after 1 and 3 months follow-up, respectively (P < 0.001). In remaining patients, the mean antibody titer after 14 and 20 months follow-up was 144 ± 164.2 and 45.2 ± 34 mu/ml, respectively (P < 0.001). Conclusion: Response to vaccination at short time in two groups was very good but after 14 months, the antibody titer decreased and the decline of antibody titer continued until 20 months. Keywords: Hepatitis B, Vaccination, Hemodialyhttp://jims.mui.ac.ir/index.php/jims/article/view/1927
spellingShingle Ali Momeni
Soleiman Kheiri
Zahra Khadivi
The Effect of Two Methods of HepatitisB Vaccination in Hemodialysis Patients (20-Months Follow-Up)
مجله دانشکده پزشکی اصفهان
title The Effect of Two Methods of HepatitisB Vaccination in Hemodialysis Patients (20-Months Follow-Up)
title_full The Effect of Two Methods of HepatitisB Vaccination in Hemodialysis Patients (20-Months Follow-Up)
title_fullStr The Effect of Two Methods of HepatitisB Vaccination in Hemodialysis Patients (20-Months Follow-Up)
title_full_unstemmed The Effect of Two Methods of HepatitisB Vaccination in Hemodialysis Patients (20-Months Follow-Up)
title_short The Effect of Two Methods of HepatitisB Vaccination in Hemodialysis Patients (20-Months Follow-Up)
title_sort effect of two methods of hepatitisb vaccination in hemodialysis patients 20 months follow up
url http://jims.mui.ac.ir/index.php/jims/article/view/1927
work_keys_str_mv AT alimomeni theeffectoftwomethodsofhepatitisbvaccinationinhemodialysispatients20monthsfollowup
AT soleimankheiri theeffectoftwomethodsofhepatitisbvaccinationinhemodialysispatients20monthsfollowup
AT zahrakhadivi theeffectoftwomethodsofhepatitisbvaccinationinhemodialysispatients20monthsfollowup
AT alimomeni effectoftwomethodsofhepatitisbvaccinationinhemodialysispatients20monthsfollowup
AT soleimankheiri effectoftwomethodsofhepatitisbvaccinationinhemodialysispatients20monthsfollowup
AT zahrakhadivi effectoftwomethodsofhepatitisbvaccinationinhemodialysispatients20monthsfollowup